2 thi3me 1 dustr1

[chilli16]

Please look for

1
A Comparison of the Steady-State Pharmacokinetics and Pharmacodynamics of a Novel Rapid-Acting Insulin Analog, Insulin Glulisine, and Regular Human Insulin in Healthy Volunteers Using the Euglycemic Clamp Technique[1]
R. H. A. Becker1 , A. D. Frick1 , F. Burger2 , H. Scholtz2 , J. H. Potgieter2
Exp Clin Endocrinol Diabetes 2005; 113(5): 292-297

DOI:

http://dx.doi.org/10.1055/s-2005-865637

2
Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp
L. Heinemann, C. Weyer, K. Rave, O. Stiefelhagen, M. Rauhaus, T. Heise
Exp Clin Endocrinol Diabetes 1997; 105(3): 140-144

DOI:

http://dx.doi.org/10.1055/s-0029-1211742

3.
Bioequivalence of Jusline following subcutaneous administration in healthy subjects
K.A. Al-Rubeaan1, N.M. Al-Daghri2, K.M. Alkharfy3, O.S. Al-Attas2, F.S. Hanif1, N.S. Metias1, S.L.B. Sabico2
Int. Journal of Clinical Pharmacology and Therapeutics, Volume 46 - July (382 - 388)

DOI:

http://dx.doi.org/10.5414/CPP46382

Код: Выделить всё

http://www.dustri.com/article_response_page.html?artId=4334&doi=10.5414/CPP46382&L=0